| Apr 14 2025 |
Old North State Report – April 14, 2025 |
Nelson Mullins |
| Apr 14 2025 |
HHS Restructuring and Workforce Reductions – Key Implications for the Health Care Industry |
Mintz |
| Apr 11 2025 |
New FDA Criteria for Labeling Food as "Healthy" |
Womble Bond Dickinson (US) LLP |
| Apr 11 2025 |
New Mexico Will Phase Out Products Containing Intentionally Added PFAS and Require Reporting; Exemptions Include Fluoropolymers |
Bergeson & Campbell, P.C. |
| Apr 11 2025 |
McDermott+ Check-Up: April 11, 2025 |
McDermott Will & Emery |
| Apr 11 2025 |
CODEX ALIMENTARIUS: Main Outcome of the 55th Committee on Food Additives (CCFA55) |
Keller and Heckman LLP |
| Apr 11 2025 |
District Court Strikes Down FDA’s LDT Rule, Opens the Door for Challenges to FDA’s Regulation of Other “Services” as Medical Devices |
Squire Patton Boggs (US) LLP |
| Apr 10 2025 |
REACH and GHS in Latin America — A Conversation with Melissa Owen [PODCAST] |
Bergeson & Campbell, P.C. |
| Apr 10 2025 |
Pennsylvania Federal Court Follows State Ruling That Medical Marijuana Use Is Not a Disability Under State Law |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 10 2025 |
A Texas Federal Court Sides with Laboratories, But There May Be Unintended Consequences for FDA |
Mintz |
| Apr 9 2025 |
EC Scientific Committee Begins Public Consultation on Preliminary Opinion on Hydroxyapatite (Nano) |
Bergeson & Campbell, P.C. |
| Apr 9 2025 |
New Mexico Becomes Third State in the U.S. to Legalize Access to Psilocybin |
Foley & Lardner LLP |
| Apr 9 2025 |
Sick of Healthcare? Healthcare Benefit Update for Employers – What to Watch in 2025 |
Babst, Calland, Clements & Zomnir, P.C. |
| Apr 8 2025 |
EPA Announces Changes to Pesticide Data Submission Process for Data Matrix Form |
Bergeson & Campbell, P.C. |
| Apr 8 2025 |
The LDT Final Rule Bites the Dust: Examining the Repercussions of the Federal Court’s Vacatur and What the Future May Hold |
Epstein Becker & Green, P.C. |
| Apr 8 2025 |
Litigation Minute: Emerging Contaminants: Defending Litigation |
K&L Gates LLP |
| Apr 7 2025 |
Old North State Report – April 7, 2025 |
Nelson Mullins |
| Apr 7 2025 |
NSF Announces PFAS-Free Certification for Nonfood Compounds and Food Equipment Materials |
Bergeson & Campbell, P.C. |
| Apr 7 2025 |
Healthcare Preview for the Week of: April 7, 2025 [Podcast] |
McDermott Will & Emery |
| Apr 7 2025 |
Jepson Claim Format Does Not Avoid Written Description Scrutiny |
Foley & Lardner LLP |
| Apr 7 2025 |
LDT Final Rule Series: Part 4 – Rule Overturned by Federal District Court |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 4 2025 |
Unlocking the Secrets of the Endocannabinoid System: A New Frontier in Therapeutic Cannabis Research for Adolescents |
Womble Bond Dickinson (US) LLP |
| Apr 4 2025 |
Two Class Actions Target Supplement Promoted for Increasing GLP-1 |
Keller and Heckman LLP |
| Apr 4 2025 |
Mexico Bans the Cultivation of Genetically Modified Corn, Opening Door for Other Restrictions in the Future |
Beveridge & Diamond PC |
| Apr 4 2025 |
Court Rejects Challenge to FDA Approval of Ammonia-Reducing Animal Drug |
Keller and Heckman LLP |
| Apr 4 2025 |
Texas Senate Approves Two Bills Aimed at Artificial Food Additives |
Keller and Heckman LLP |
| Apr 4 2025 |
Summary Judgment Granted in Heavy Metals in Chocolate Class Action |
Keller and Heckman LLP |
| Apr 3 2025 |
Hatch-Waxman Litigation Expenses Are Deductible Under Internal Revenue Code § 162(a) |
McDermott Will & Emery |
| Apr 3 2025 |
Court Sides with RICO Complainant Who Received Tainted Medical Marijuana and with FDA on Regulating E-Cigarettes - SCOTUS Today |
Epstein Becker & Green, P.C. |
| Apr 3 2025 |
Supreme Court Rules Lost Wages May Be Recoverable Under RICO For False Advertising After Drug Test Dismissal |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 2 2025 |
USDA Will Fund 543 Projects in 29 States Through Higher Blends Infrastructure Incentive Program |
Bergeson & Campbell, P.C. |
| Apr 2 2025 |
GLP-1 Receptor Agonists: Drug Litigation Overview and Trends |
Foley & Lardner LLP |
| Apr 2 2025 |
March 2025 PFAS Legislative Developments |
CMBG3 Law |
| Apr 2 2025 |
Texas Court Vacates FDA’s Laboratory Developed Test (LDT) Final Rule |
Foley & Lardner LLP |
| Apr 1 2025 |
In Landmark Ruling, Eastern District of Texas Strikes Down FDA’s Final Rule Regulating Laboratory Developed Tests |
Polsinelli PC |
